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Abstract
Background: Assessment of cancer incidence trends within the U.S. have mostly relied upon Surveillance, Epidemiology,
and End Results (SEER) data, with implicit inference that such is representative of the general population. However, many
cancer policy decisions are based at a more granular level. To help inform such, analyses of regional cancer incidence data
are needed. Leveraging the unique resource of National Program of Cancer Registries (NPCR)-SEER, we assessed whether
regional rates and trends of esophageal cancer significantly deviated from national estimates.
Methods: From NPCR-SEER, we extracted cancer case counts and populations for whites aged 45–84 years by calendar year,
histology, sex, and census region for the period 1999–2008. We calculated age-standardized incidence rates (ASRs), annual
percent changes (APCs), and male-to-female incidence rate ratios (IRRs).
Results: This analysis included 65,823 esophageal adenocarcinomas and 27,094 esophageal squamous cell carcinomas
diagnosed during 778 million person-years. We observed significant geographic variability in incidence rates and trends,
especially for esophageal adenocarcinomas in males: ASRs were highest in the Northeast (17.7 per 100,000) and Midwest
(18.1). Both were significantly higher than the national estimate (16.0). In addition, the Northeast APC was 62% higher than
the national estimate (3.19% vs. 1.97%). Lastly, IRRs remained fairly constant across calendar time, despite changes in
incidence rates.
Conclusion: Significant regional variations in esophageal cancer incidence trends exist in the U.S. Stable IRRs may indicate
the predominant factors affecting incidence rates are similar in men and women.
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Introduction
Although relatively uncommon in the United States (U.S.), with
17,460 incident cases estimated in 2012 [1], esophageal cancer is
one of the most deadly malignancies with a 5-year survival rate of
about 17% [2]. The two primary histological subtypes –
esophageal adenocarcinoma (EA) and esophageal squamous
carcinoma (ESCC) – account for 94% of all histologically-specified
esophageal cancers [2]. Each histology is biologically distinct, with
highly dissimilar risk profiles, differences in subsite localization,
and stark differences with regard to worldwide incidence trends
[3]. In the U.S., the incidence rate of EA has increased by 650% in
white males over the last 35 years [4,5]. In sharp contrast, the
incidence of ESCC has steadily decreased. Although analyses of
the National Cancer Institute’s Surveillance, Epidemiology, and
End Results (SEER) registries provide essential information on
U.S. cancer trends, its ability to inform on regional trends is
limited given that it includes only 28% of the U.S. population
limited to specific geographic locales [6,7].
Identifying regional patterns of esophageal cancer incidence
may inform intervention strategies, afford the opportunity to
elucidate causes for regional differences, and provide relevant
information vital for making local cancer policy decisions.
Population coverage across all census regions is necessary for such
analyses and can be achieved when SEER registries are combined
with registries that have participated in the Centers for Disease
Control and Prevention’s National Program of Cancer Registries
(NPCR) [5,8]. Leveraging the unique resources of NPCR and
SEER, we assessed whether incidence rates and trends of EA and
ESCC, as well as sex differences of these diseases, varied by
geographic census region.
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Materials and Methods
Data source
Incident primary esophageal cancer cases were identified from
population-based statewide cancer registries that participated in
the NPCR or SEER programs [6,8]. Each resource uses uniform
methodologies for data collection and reporting [9]. When
combined, the registries collect incidence data for the entire
U.S. population. Data were continuously updated and monitored
annually for quality. Data from statewide registries that met strict
high-quality standards for all years (1999–2008) were included in
the study [10–12]. Data in six states (AR, NC, MS, SD, TN, VA)
and the District of Columbia did not meet case ascertainment and
quality criteria for at least one of the years of the analytic period
and were thus excluded. Data included from the remaining 44
states provided cancer registration coverage for 85.3% of the U.S.
for the period 1999–2008. Given the number of esophageal cancer
cases, after stratification by sex and histology, the geographic units
were grouped using census region [13]. Figure 1 illustrates the
states included in each of the four U.S. census regions. Coverage
varied slightly by census region with nearly complete population
coverage of the Northeast (100%), West (100%), and Midwest
(98.8%), and less population coverage in the South (76.0%).
Esophageal cancer cases were classified by histologic subtype
using morphology codes from the International Classification of
Diseases for Oncology, Third Edition (ICD-O-3). EAs were
defined as ICD-O-3: 8140–8575 and ESCC were defined as ICD-
O-3: 8050–8084. Cases were restricted to whites aged 45–84 years
of age because data for other races and ages were limited after
stratifications by histology, sex, and census region. The variables
captured and calculated were cancer count, person-years, and
incidence rate per 100,000 age-adjusted to the 2000 US Standard
Population (19 age groups – Census P25–1130). SEER*Stat
software version 7.0.5 [14] was used to prepare counts of
esophageal cancer and underlying populations by age and year
of diagnosis for whites for the period 1999–2008.
Statistical analyses
Age-standardized incidence rates (ASRs) were calculated for
each calendar year and by histologic subtype (EA and ESCC), sex,
and census region. Male-to-female incidence rate ratios (IRRs)
were calculated by using the male ASR as the numerator and the
female ASR as the denominator. Rates provided are per 100,000
person-years and 95% confidence intervals (CIs) were calculated
for rates and ratios using the modification of Tiwari et al. [15].
Annual percent changes (APCs) were estimated by fitting a
weighted-least-squares regression to the natural logarithm of the
ASR for the period 1999–2008, with 95% CIs calculated using a
normal approximation [16]. All data analyses were performed
using SEER*Stat software version 7.0.5 [14] and SAS Software
9.2 [17].
Census region ASRs, APCs, and IRRs were compared with the
national ASR, APC, and IRR and tested for statistically significant
differences. To account for correlations due to overlapping
regions, the method proposed by Tiwari et al. [18,19] was used
to test the difference of the ASRs, and the method proposed by
Walters et al. [16] was used to test the difference of the APCs. A
modified method proposed by Tiwari et al. that compares ratios
and accounts for correlations due to the overlapping regions was
used to test differences of the IRRs [20]. Differences between
census regions and estimated national statistics were considered
significant at P,0.05.
Results
This analysis included 65,823 EA and 27,094 ESCC cases
diagnosed in white adults aged 45–84 years during more than
778 million person-years for the calendar period 1999–2008. As
shown in Table 1, the numbers of esophageal cancer cases were
fairly evenly spread across census regions, with a slightly higher
number of EA cases in the Midwest and a higher number of ESCC
cases in the South, without adjustment for regional differences in
age, sex and population size. Stark sex disparities were observed
for both histological subtypes. The majority of EA and ESCC
cases were diagnosed in men (86.5% and 64.0%, respectively).
With regards to age, the largest proportion of EA cases and ESCC
cases occurred in those 65–74 years.
Estimates of national ASRs and APCs for the 10-year period are
shown in Table 2. During 1999–2008, the overall ASRs for EA in
men and women were 16.03 (95% CI: 15.90, 16.17) and 2.08
(95% CI: 2.04, 2.13) per 100,000 person-years, respectively. The
incidence of EA increased in both sexes in the U.S. with APC
estimates of 1.97% (95% CI: 1.67, 2.27) for men and 2.18% (95%
CI: 1.44, 2.92) for women per year of calendar time. The national
age-standardized incidence rate for ESCC was 4.93 (95% CI:
4.85, 5.00) per 100,000 in men and 2.30 (95% CI: 2.25, 2.34) per
100,000 in women. In contrast to EA, the incidence of ESCC in
the U.S. decreased at 23.41% (95% CI: 23.91, 22.91) and
23.13% (95% CI: 23.80, 22.45) in men and women, respec-
tively, per year of calendar time.
Table 2 also displays these statistics by U.S. census region. As
shown, for EA, there were significant regional variations in the
ASR and APC. Compared with the national ASR of EA, the
ASRs for the Northeast and Midwest were both significantly
higher, and the South and West were both significantly lower, for
both males and females. The APC for men in the Northeast was
62% higher than the national average (3.19% compared with
1.97%, P,0.001). Significantly lower APCs were observed for
men in the Midwest and West, with the West having the lowest
APC at 0.80% (0.15, 1.45). EA in females exhibited a similar
pattern to males, with the highest APC occurring in the Northeast
at 4.07% (2.62, 5.54) and lowest occurring in the West at 20.52%
(22.13, 1.12) and each significantly different than the national
APC (P,0.001).
Figure 1. United States census regions. The states included in the
Northeast, Midwest, South, and West census regions are highlighted.
Coverage varied slightly by census region with nearly complete
population coverage of the Northeast (100%), West (100%), and
Midwest (98.8%), and slightly less population coverage in the South
(76.0%).
doi:10.1371/journal.pone.0067913.g001
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Some significant variations between regional and the national
ASRs and APCs were also observed for ESCC (Table 2). Similar
to patterns for EA in males, the male incidence rate of ESCC in
the Northeast (5.81, 95% CI: 5.64, 5.98) was significantly higher
(P,0.001) than the national average (4.93, 95% CI: 4.85, 5.00)
and the male incidence rate of ESCC in the West (4.29, 95% CI:
4.15, 4.44) was significantly lower (P,0.001). Unlike EA, the APC
of ESCC was decreasing during the 10-year period. Although
ESCC was also decreasing in the Northeast, men in the Northeast
had an APC (22.26%, 95% CI: 23.27, 21.25) that was
significantly less than the national trend (23.41%, 95% CI:
23.91, 22.91, P,0.01). Women in the Northeast had a slightly,
yet significantly, higher incidence rate (2.52, 95% CI: 2.42, 2.62)
than the national average (2.30, 95% CI: 2.25, 2.34, P,0.001),
although the difference in the APC in the Northeast compared
with the national APC was not statistically significant.
The national IRR for EA was 7.70 (95% CI: 7.52, 7.87)
(Table 2). Some regional EA IRRs did vary significantly from the
national EA IRR–the Northeast had a significantly lower IRR
(7.04, 95% CI: 6.74, 7.36) and South had a significantly higher
IRR (8.43, 95% CI: 8.05, 8.83). The national ESCC IRR was 2.14
(95% CI: 2.09, 2.20). The ESCC IRR in the West (1.79, 95% CI:
1.70, 1.89) was significantly lower than the national IRR. Both the
Northeast (2.31, 95% CI: 2.20, 2.43) and South (2.25, 95% CI:
2.14, 2.36) had higher IRRs than the national IRR for ESCC.
Figure 2 shows the age-adjusted incidence rates over calendar
time stratified by histology, sex, and census region. Across all
regions the incidence rate of EA has been steadily increasing,
although regional variations are apparent. Consistent with the
ASRs shown in Table 2, the male EA incidence rates in Northeast
and Midwest census regions have been consistently higher than
incidence rates in the South and West. Similar patterns, albeit with
lower incidence rates, were observed for females in these census
regions.
In contrast to EA rates across census region, ESCC has steadily
decreased over the period analyzed (Figure 2). The Northeast
region exhibited higher incidence rates in men at every year
compared with the other three regions, which had similar rates
and trends. For female ESCC cases, each region was decreasing
similarly with little regional variation observed. The most recent
incidence rates shown in Figure 2 for 2008, indicates that the
Northeast had the highest rates of EA and ESCC in both sexes.
The IRRs over calendar time displayed small fluctuations for both
EA and ESCC, yet no pattern of change over time or between
census regions were apparent.
Discussion
In this analysis we observed significant geographic variability in
EA and ESCC incidence rates by census region. The highest ASRs
for EA were observed in the Northeast and Midwest for both men
and women and were significantly higher than the national
average (Table 2). In contrast, the South and West had
significantly lower age-standardized rates than the national
average. Our study demonstrates that national cancer estimates
do not adequately address the current, and potentially future,
esophageal cancer burden for a specific region.
Census regions differed by 3.77 per 100,000 in male EA, which
is equivalent to ,25% more cases per 100,000 in each of the
Northeast and Midwest census regions relative to the West. The
APC across census regions was also highly variable and has
important implications. The APC for men in the Northeast was
3.19% (95% CI: 2.58, 3.81) in sharp contrast to 0.80% (95% CI:
0.15, 1.45) in the West. These data indicate a slight, but significant
increase in EA for men in the West during the 10-year period.
Although there are no clear explanations for these significant
variations in EA incidence rates by census region, it is likely that
key exposures important to this malignancy’s pathogenesis in the
U.S. population are causal to our observations. It is also possible
that regional variation in EA is driven by a differential exposure to
a strong, highly prevalent and yet unidentified causal factor as
Edgren et al. hypothesized has led to the dramatic increase in EA
incidence [21]. Thus further elucidation of our observations could
help identify such a factor and aid preventative efforts across U.S.
regions.
Our study also demonstrates that regional variations in ESCC
rates and trends existed in 1999–2008. In men, the ASR for the
Northeast indicated a higher cancer burden compared with other
regions, and this was significantly different from the national
estimate. In addition, the APC for Northeast men declined
significantly less than the decline observed in the national average.
Also mirroring the trends of EA in men, the ASR for ESCC in the
West was the lowest of all census regions and significantly less than
the national average.
It is not clear why the Northeast has had a generally higher
esophageal cancer burden for both histologic subtypes relative to
the other census regions assessed, or why the West consistently has
Table 1. Esophageal cancer cases included for analysis: NPCR
and SEER, whites, ages 45–84, 1999–2008.
EA ESCC
Count % Count %
National Total 65,823 (70.8)* 27,094 (29.2)*
Regional Counts
Northeast 16,137 (24.5) 6,936 (25.6)
Midwest 19,342 (29.4) 6,819 (25.2)
South 16,852 (25.6) 7,632 (28.2)
West 13,492 (20.5) 5,707 (21.1)
Total 65,823 (100.0) 27,094 (100.0)
Sex
Male 56,965 (86.5) 17,339 (64.0)
Female 8,858 (13.5) 9,755 (36.0)
Total 65,823 (100.0) 27,094 (100.0)
Age (years)
45–54 9,453 (14.4) 2,872 (10.6)
55–64 18,369 (27.9) 6,519 (24.1)
65–74 21,042 (32.0) 9,540 (35.2)
75–84 16,959 (25.8) 8,163 (30.1)
Total (45–84) 65,823 (100.0) 27,094 (100.0)
Years
1999–2000 11,159 (17.0) 5,832 (21.5)
2001–2002 12,128 (18.4) 5,572 (20.6)
2003–2004 13,209 (20.1) 5,494 (20.3)
2005–2006 14,324 (21.8) 5,202 (19.2)
2007–2008 15,003 (22.8) 4,994 (18.4)
Total (1999–2008) 65,823 (100.0) 27,094 (100.0)
*Row percentages.
Abbreviations: EA, esophageal adenocarcinoma; ESCC, esophageal squamous
cell carcinoma.
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a lower burden of each of these histologies, especially given that
EA and ESCC are distinct in their risk factors. To supplement our
findings we explored regional prevalence of exposure to major risk
factors of these malignancies extracted from the 2007 NHIS
survey data (Table S1). The prevalence of obesity was higher in
the Northeast and Midwest, which may lead to increased risk of
EA in those census regions. Regional variations in gastroesoph-
ageal reflux and cigarette smoking were inconsistent with our
observed EA incidence trends by census region. Regional
variations in alcohol consumption and cigarette smoking, however,
were consistent with ESCC trends observed in our analysis. The
Northeast had the highest prevalence of moderate or heavy
alcohol consumption and above average ever smoking in both
sexes. The higher regional exposure to smoking and drinking may
partly explain why rates of ESCC are not declining as rapidly in
the Northeast as other regions. Although data is somewhat
suggestive, it does not clearly support significant differences in risk
factor prevalence by census region in the year evaluated.
Furthermore geographic variation in exposure to risk factors and
trends in prevalence would be better explored in data which can
also take into account the latency period, often estimated to be
prolonged, between exposure and diagnosis of disease. This should
be a focus of future studies.
Male predominance is a striking feature of esophageal cancer
and, as reported in many other studies, we observed a very high
IRR for EA (7.70, 95% CI: 7.52, 7.87) and a moderately high IRR
for ESCC (2.14, 95% CI: 2.09, 2.20). Interestingly the IRR for
each histotype remained fairly constant across the decade, even as
the incidence rates were changing. This suggests that the
underlying etiology of the sex disparity is unrelated to the factors
that are driving increases in the incidence rate of EA and decreases
in the incidence of ESCC. It also suggests that the predominant
factors affecting changes in incidence rates over calendar time
affect each sex in a relatively similar manner.
This study provides updated national and novel regional
estimates of esophageal cancer incidence and trends by histology
and sex. Our findings extend the timeframe analyzed in previous
publications and demonstrate that ESCC incidence rates have
continued to fall through 2008 [22–26]. We also observed that EA
rates in the U.S. continued to increase with an APC of 1.97%
(95% CI: 1.67, 2.27). Geographic differences in esophageal cancer
incidence have been previously reported, however such studies
relied on data with poor geographic distribution and focused on
rates in individual cancer registries [3,27]. The focus of our
analysis was to assess sex and regional differences which builds on
the foundation set by Trivers et al in her analysis of 1998–2003
data in NPCR and SEER that reported incidence rates and trends
in esophageal cancer by census region [28]. The extended period
and stratification by sex provides the ability to assess our
hypotheses using sex specific overall rates as well as good statistical
power to detect changes over calendar time.
There are several limitations of our study. NPCR and SEER
registries are important and rich data sources for examining cancer
incidence rates and trends, however, risk factor information is not
available, so we were unable to directly investigate the influence of
known risk factors. In order to provide stable estimates, our analyses
were restricted to whites and, therefore, are not generalizable to
other races. Cancer registry coverage across census regions was not
uniform and it is possible that the missing population could differ
from the covered population. Lastly, given our stratification by
histology and sex, data were too sparse to analyze by census division
or state level. To examine differences in rates and trends by census
division or state, future studies could limit the analyses to men or
combine data for each sex.
Our analysis has several notable strengths. Our study is the first
to examine incidence rates and trends over time for esophageal
cancer by census region. Despite the variation in coverage, the
information provided by the NPCR-SEER data has far greater
population coverage than SEER alone (85% versus 28% after
exclusions). The analysis relied on data from statewide registries
that met strict high-quality standards and encompassed a large
proportion of the U.S. population, thus allowing for precise
estimates of incidence rates by calendar year and age-specific
incidence rates during the decade investigated.
Table 2. Age-Standardized Incidence Rates and Annual Percent Changes Stratified by Histology, Sex, and Region in Whites, Aged
45–84, 1999–2008.
Male Female Male-to-Female
EA ASR‘ APC ASR‘ APC Rate Ratio
National 16.03 (15.90, 16.17) 1.97 (1.67, 2.27) 2.08 (2.04, 2.13) 2.18 (1.44, 2.92) 7.70 (7.52, 7.87)
Census
Region
Northeast 17.67 (17.37, 17.97)** 3.19 (2.58, 3.81) 2.51 (2.41, 2.61)** 4.07 (2.62, 5.54)** 7.04 (6.74, 7.36)
Midwest 18.09 (17.82, 18.37)** 1.44 (0.90, 1.98) 2.36 (2.27, 2.45)** 2.48 (1.11, 3.87) 7.68 (7.37, 8.01)
South 14.37 (14.14, 14.60)** 2.59 (2.01, 3.18) 1.70 (1.63, 1.78)** 2.08 (0.58, 3.06) 8.43 (8.05, 8.83)
West 14.32 (14.05, 14.58)** 0.80 (0.15, 1.45) 2.08 (0.58, 3.60)** 20.52 (22.13, 1.12)** 7.86 (7.47, 8.27)
ESCC
National 4.93 (4.85, 5.00) 23.41 (23.91, 22.91) 2.30 (2.25, 2.34) 23.13 (23.80, 22.45) 2.14 (2.09, 2.20)
Census
Region
Northeast 5.81 (5.64, 5.98)** 22.26 (23.27, 21.25)* 2.52 (2.42, 2.62)** 22.29 (23.65, 20.91) 2.31 (2.20, 2.43)
Midwest 4.85 (4.70, 4.99) 23.84 (24.83, 22.85) 2.17 (2.08, 2.26)** 22.68 (24.03, 21.31) 2.23 (2.12, 2.34)
South 4.87 (4.73, 5.00) 23.46 (24.39, 22.53) 2.16 (2.08, 2.25)** 23.13 (24.42, 21.83) 2.25 (2.14, 2.36)
West 4.29 (4.15, 4.44)** 23.71 (24.83, 22.57) 2.40 (2.30, 2.50) 24.41 (25.79, 23.02) 1.79 (1.70, 1.89)
Abbreviations: ASR, age-standardized incidence rate; APC, annual percentage change; EA, esophageal adenocarcinoma; ESCC, esophageal squamous cell.
‘per 100,000 person-years.
bold indicates significantly different than national rate (P#0.05), *P,0.01, **P,0.001.
doi:10.1371/journal.pone.0067913.t002
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Figure 2. Age-adjusted incidence rates stratified by histology, sex, and region in whites, aged 45–84, 1999–2008. Panel A and B
illustrate the age-adjusted incidence rate per 100,000 person-years by census region of the histologic subtype EA in men and women, respectively.
Panel C shows the male-to-female incidence rate ratio (IRRs) of EA by calendar year. Panel D and E depicts the age-adjusted incidence rate of ESCC in
men and women, respectively. Panel F shows the male-to-female incidence rate ratio (IRRs) of ESCC by calendar year. Rates graphed are per 100,000
person-years.
doi:10.1371/journal.pone.0067913.g002
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Our comprehensive analysis demonstrates significant regional
variations in the incidence and annual percent change in incidence
rates of EA and ESCC among whites in the U.S. It will be
interesting to see whether future studies of EA can identify risk
factors that drive some of the regional heterogeneity of this
malignancy, including the higher incidence rates in the Northeast
and Midwest. We hypothesize here that the trends observed for
ESCC may be influenced by regional exposure to risk factors,
since we observed cigarette smoking and alcohol consumption
patterns that roughly underlie the observed incidence rates of this
malignancy. Novel study designs that can test these hypotheses
further are needed. Finally, the stability of the IRRs for both
histologic types is indicative that the causes of sex disparities in
these diseases are potentially distinct from the extensive regional
differences in incidence observed. Our findings underscore the
importance of examining geographic and sex disparities in
esophageal cancer and suggest that national cancer estimates
may not adequately reflect specific geographic locales.
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Table S1 NHIS 2007: Prevalence of Major Risk Factors of EA
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